Approved uses of platform data

The following research proposals include both those approved by the platform’s independent Data Access Committee and those which are ISARIC Partner Analyses. Please review these proposals before submitting a Data Access Request. In the interest of maximising the production of evidence to reduce the impact of COVID-19, the platform aims to avoid unnecessary duplication of analyses.

Creative rendition of SARS-COV-2 virus particles. Note: not to scale

Credit: National Institute of Allergy and Infectious Diseases, NIH

DAC approved proposals

These analyses have been approved by the COVID-19 Data Access Committee.

Approved uses of platform data

DAC approved proposals

The interactive effect of clinical and non-clinical features in COVID-19 patients with chronic respiratory diseases (CRDs): a global perspective

Tsinghua University, China, Karolinska Institute, Sweden, and University College London, UK

The impact of SARS-CoV-2 variants of concern on disease severity of children

University of Queensland, Australia, NIHR Clinical Research Facility Southampton and University of Southampton, UK

Predicting hospitalisation of COVID-19 patients using intelligent wearable technology with machine learning

Durban University of Technology, South Africa

Global COVID-19 Clinical Data Platform for clinical characterization and management of hospitalized patients with suspected or confirmed COVID-19

World Health Organization, Switzerland

Formative Evaluation of a Minimally Viable COVID-19 Dataset

C-Path, United States

Pathogen evolution towards Evolutionarily Stable Strategies (ESS) in a socially age-structured epidemic

University of Oslo, Norway, University of Copenhagen, Denmark

Avoiding preventable deaths through the provision of essential treatment in critical illness in the COVID-19 pandemic

London School of Hygiene & Tropical Medicine and Centre for Global Development, UK, Ifakara Health Institute, Tanzania, and Karolinska Institute, Sweden

Sepsis in COVID-19

Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China

Read the full application

COVID-Intelligence, a Bayesian Network Clinical Decision Support System for COVID-19

Monash University, Australia

Clinical presentation and outcome of hospitalised Dutch patients with COVID-19

Franciscus Gasthuis and Vlietland, Rotterdam, The Netherlands

ISARIC Partner Analyses

ISARIC COVID-19 Clinical Data Reports

Variation in management and outcomes of hospitalised patients with COVID-19 among low-middle-, upper-middle- and high-income countries

King Saud Bin Abdulaziz University for Health sciences, King Abdullah International Medical Research Center, and King Abdulaziz Medical City, Saudi Arabia

Exploring associations between ethnicity, in-hospital complications and COVID-19 outcomes in the United Kingdom, Brazil, and South Africa

Liverpool School of Tropical Medicine, UK, Oswaldo Cruz Foundation and Pontifical Catholic University of Rio de Janeiro, Brazil, National Institute for Communicable Diseases, South Africa

Statistical and machine learning methods for predicting risk of pulmonary embolism and death in patients with COVID-19

University of Oxford and Queen Elizabeth Hospital, UK, Digital Health Research and Innovation Unit, Malaysia

Comparing clinical presentation and outcomes of hospitalised SARS-CoV-2 patients before and after the spread of the Omicron variant

University of Oxford, UK, National Institute of Communicable Diseases, South Africa, King Abdulaziz Medical City, Saudi Arabia, Sunnybrook Health Sciences Centre, Canada, University College Dublin, Ireland, Franciscus Gasthuis & Vietland, Netherlands, University Hospital of Tubingen, Germany

The relative influence of clinical and sociodemographic variables on the long-term COVID-19-associated QALYs lost

Harvard University, USA, University of Oxford and Imperial College London, UK, Universidad de La Sabana, Colombia, Oslo University Hospital, Norway

Impact of COVID-19 in Pregnancy

Mount Kenya University and Ministry of Health, Kenya, University of Oxford and University of Birmingham, UK, Ifakara Health Institute, Tanzania

Automatic Identification of Signals in Clinical Notes using Natural Language Processing

University of Oxford

A tool-box for epidemic research: the ISARIC Clinical Characterisation group on strategies to simplify and improve collaboration-fuelled research during health emergencies

University of Oxford, UK, Apollo Hospitals, India, National Public Health Institute, Liberia

Cardiovascular comorbidities and complications in hospitalized patients with COVID-19

University of Oxford, UK, Serdang Hospital and Centre for Clinical Outcome Research, Malaysia

Characteristics, presentation, risk factors, treatments and outcomes in patients with cancer and COVID-19 (ARC: ISARC International Cancer)

University of Oxford and University of Liverpool, UK, and Universidad del Cauca and Pontificia Universidad Javeriana, Colombia

Characterising SARS-CoV-2 Omicron vs Delta variant in terms of vaccination status, clinical presentation and outcomes

University of Oxford, UK

Clinical outcomes in children with severe Covid-19: a retrospective study in limited vs. enormous resource countries

National Cardiovascular Center Harapan Kita, Universitas Udayana, and Saiful Anwar Hosptial, Indonesia, and Chonnam National University Children’s Hospital, South Korea

Liver function abnormalities in patients admitted with COVID-19 and association with outcomes: A draft analysis plan using data collected by the ISARIC Collaborators

Apollo Hospitals, India, University of Toronto, Canada, and University of Oxford, and ISARIC, UK

Applicability of commonly used COVID-19 clinical case definitions and severity score amongst patients hospitalized with COVID-19 in LMICs

Clinical Research Unit Nepal and Centre for Tropical Medicine and Global Health, University of Oxford, UK

Potassium in COVID-19 patients admitted to hospital

Inserm, Nancy Regional and University Hospital Center and INI-CRCT Network, France, and Hospital Civil de Guadalajara, Mexico

Influence of nutrition status on COVID-related outcome

CUB-Hopital Erasme, Belgium

Utility of measures of oxygenation for COVID-19 case management and outcome

University of Oxford, UK, Apollo Hospitals Group, India, and Luxembourg Institute of Health, Luxembourg

Coagulopathy and thrombosis among COVID-19 patients

University of Utah School of Medicine, USA and Fundação Oswaldo Cruz, Brazil

Neurological manifestation and outcome for patients admitted to hospital with COVID-19

Johns Hopkins University School of Medicine, USA and University of Cape Town, South Africa

Acute Kidney Injury in COVID-19

University of Queensland, Australia and Universidad Mayor de San Simon, Cochabamba, Bolivia

Analysis of the ISARIC International COVID-19 Critically Ill Cohort

British Columbia Children's Hospital, Canada and Universidad De La Sabana, Columbia

Characteristics and outcomes of an international cohort of hospitalised patients with Covid-19

University of Oxford, UK

International comparison of age-specific presenting symptoms for patients admitted to hospital with coronavirus disease 2019

University of Oxford, UK

Time variation in the inpatient journey

University of Oxford, UK